IMNM – immunome, inc. (US:NASDAQ)

News

Immunome: Upcoming NDA, Valuation, And Investment Case [Seeking Alpha]
Immunome (IMNM) was downgraded by Wall Street Zen from "hold" to "sel
Did Reduced 2025 Losses and NDA Plans Just Shift Immunome's (IMNM) Investment Narrative? [Yahoo! Finance]
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Immunome (IMNM) had its price target raised by Craig Hallum from $33.00 to $36.00. They now have a "buy" rating on the stock.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com